Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review

Elspeth Rona Morrison, Zofia Helena Miedzybrodzka, Doris Margaret Campbell, Neva Elizabeth Haites, B.j. Wilson, M.s. Watson, Michael Greaves, Mark Adrian Vickers

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

DNA samples collected as part of a large population-based case-control study were genotyped to examine the associations of five prothrombotic gene polymorphisms with pre-eclampsia (PE) and gestational hypertension (GH). The polymorphisms studied were: G1691A in Factor V (Factor V Leiden: FVL). prothrombin G20210A, methylene-tetrahydrofolate reductase (MTHFR) C677T, plasminogen activator inhibitor-1 4G/5G and the platelet collagen receptor a, alpha(2)beta(1) C807T. A group of 404 women who developed PE were retrospectively compared with 303 women with GH and 164 control women. The frequency of genotypes did not differ significantly between cases of PE or GH and controls for any of the five polymorphisms studied, We conclude that these prothrombotic genotypes are not associated with the development of PE or GH in our population. The systematic review supports our conclusion, for all but cases of severe disease, which appear to be associated with FVL and. to a lesser extent. MTHFR C677T. There is little value in antenatal screening for prothrombotic polymorphisms to predict the development of pre-eclampsia or gestational hypertension.

Original languageEnglish
Pages (from-to)779-785
Number of pages6
JournalThrombosis and Haemostasis
Volume87
Issue number5
Publication statusPublished - May 2002

Keywords

  • pre-eclampsia
  • gestational hypertension
  • prothrombotic polymorphisms
  • Factor V Leiden
  • MTHFR
  • FACTOR-V-LEIDEN
  • ACTIVATED PROTEIN-C
  • METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISMS
  • GENETIC RISK-FACTORS
  • SEVERE PREECLAMPSIA
  • 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE
  • HEMOSTATIC ABNORMALITIES
  • COMPLICATED PREGNANCIES
  • 3'-UNTRANSLATED REGION
  • COMMON MUTATION

Cite this

Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. / Morrison, Elspeth Rona; Miedzybrodzka, Zofia Helena; Campbell, Doris Margaret; Haites, Neva Elizabeth; Wilson, B.j.; Watson, M.s.; Greaves, Michael; Vickers, Mark Adrian.

In: Thrombosis and Haemostasis, Vol. 87, No. 5, 05.2002, p. 779-785.

Research output: Contribution to journalArticle

Morrison, Elspeth Rona ; Miedzybrodzka, Zofia Helena ; Campbell, Doris Margaret ; Haites, Neva Elizabeth ; Wilson, B.j. ; Watson, M.s. ; Greaves, Michael ; Vickers, Mark Adrian. / Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. In: Thrombosis and Haemostasis. 2002 ; Vol. 87, No. 5. pp. 779-785.
@article{f6ba76f4253c4e698388ba93d88098c2,
title = "Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review",
abstract = "DNA samples collected as part of a large population-based case-control study were genotyped to examine the associations of five prothrombotic gene polymorphisms with pre-eclampsia (PE) and gestational hypertension (GH). The polymorphisms studied were: G1691A in Factor V (Factor V Leiden: FVL). prothrombin G20210A, methylene-tetrahydrofolate reductase (MTHFR) C677T, plasminogen activator inhibitor-1 4G/5G and the platelet collagen receptor a, alpha(2)beta(1) C807T. A group of 404 women who developed PE were retrospectively compared with 303 women with GH and 164 control women. The frequency of genotypes did not differ significantly between cases of PE or GH and controls for any of the five polymorphisms studied, We conclude that these prothrombotic genotypes are not associated with the development of PE or GH in our population. The systematic review supports our conclusion, for all but cases of severe disease, which appear to be associated with FVL and. to a lesser extent. MTHFR C677T. There is little value in antenatal screening for prothrombotic polymorphisms to predict the development of pre-eclampsia or gestational hypertension.",
keywords = "pre-eclampsia, gestational hypertension, prothrombotic polymorphisms, Factor V Leiden, MTHFR, FACTOR-V-LEIDEN, ACTIVATED PROTEIN-C, METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISMS, GENETIC RISK-FACTORS, SEVERE PREECLAMPSIA, 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE, HEMOSTATIC ABNORMALITIES, COMPLICATED PREGNANCIES, 3'-UNTRANSLATED REGION, COMMON MUTATION",
author = "Morrison, {Elspeth Rona} and Miedzybrodzka, {Zofia Helena} and Campbell, {Doris Margaret} and Haites, {Neva Elizabeth} and B.j. Wilson and M.s. Watson and Michael Greaves and Vickers, {Mark Adrian}",
year = "2002",
month = "5",
language = "English",
volume = "87",
pages = "779--785",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "5",

}

TY - JOUR

T1 - Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review

AU - Morrison, Elspeth Rona

AU - Miedzybrodzka, Zofia Helena

AU - Campbell, Doris Margaret

AU - Haites, Neva Elizabeth

AU - Wilson, B.j.

AU - Watson, M.s.

AU - Greaves, Michael

AU - Vickers, Mark Adrian

PY - 2002/5

Y1 - 2002/5

N2 - DNA samples collected as part of a large population-based case-control study were genotyped to examine the associations of five prothrombotic gene polymorphisms with pre-eclampsia (PE) and gestational hypertension (GH). The polymorphisms studied were: G1691A in Factor V (Factor V Leiden: FVL). prothrombin G20210A, methylene-tetrahydrofolate reductase (MTHFR) C677T, plasminogen activator inhibitor-1 4G/5G and the platelet collagen receptor a, alpha(2)beta(1) C807T. A group of 404 women who developed PE were retrospectively compared with 303 women with GH and 164 control women. The frequency of genotypes did not differ significantly between cases of PE or GH and controls for any of the five polymorphisms studied, We conclude that these prothrombotic genotypes are not associated with the development of PE or GH in our population. The systematic review supports our conclusion, for all but cases of severe disease, which appear to be associated with FVL and. to a lesser extent. MTHFR C677T. There is little value in antenatal screening for prothrombotic polymorphisms to predict the development of pre-eclampsia or gestational hypertension.

AB - DNA samples collected as part of a large population-based case-control study were genotyped to examine the associations of five prothrombotic gene polymorphisms with pre-eclampsia (PE) and gestational hypertension (GH). The polymorphisms studied were: G1691A in Factor V (Factor V Leiden: FVL). prothrombin G20210A, methylene-tetrahydrofolate reductase (MTHFR) C677T, plasminogen activator inhibitor-1 4G/5G and the platelet collagen receptor a, alpha(2)beta(1) C807T. A group of 404 women who developed PE were retrospectively compared with 303 women with GH and 164 control women. The frequency of genotypes did not differ significantly between cases of PE or GH and controls for any of the five polymorphisms studied, We conclude that these prothrombotic genotypes are not associated with the development of PE or GH in our population. The systematic review supports our conclusion, for all but cases of severe disease, which appear to be associated with FVL and. to a lesser extent. MTHFR C677T. There is little value in antenatal screening for prothrombotic polymorphisms to predict the development of pre-eclampsia or gestational hypertension.

KW - pre-eclampsia

KW - gestational hypertension

KW - prothrombotic polymorphisms

KW - Factor V Leiden

KW - MTHFR

KW - FACTOR-V-LEIDEN

KW - ACTIVATED PROTEIN-C

KW - METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISMS

KW - GENETIC RISK-FACTORS

KW - SEVERE PREECLAMPSIA

KW - 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE

KW - HEMOSTATIC ABNORMALITIES

KW - COMPLICATED PREGNANCIES

KW - 3'-UNTRANSLATED REGION

KW - COMMON MUTATION

M3 - Article

VL - 87

SP - 779

EP - 785

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 5

ER -